System Transmission

Top Signal

100#1 JOB

Activity

2163Ripe

+917 today

System

Live1m

Terminal Asset View

stockNASDAQ

BOLD

$1.11-0.89%

Boundless Bio Inc

Neutral

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

42Neutral

Live Analysis Active

Company Mission

Boundless Bio is a biotechnology company that creates new medicines to fight cancer. They focus on targeting extra DNA that some cancer cells have, which might make treatments more effective. The company makes money by partnering with larger pharmaceutical companies for research and development, and they hope to eventually sell their approved drugs to hospitals and patients.

BOL

Industry Context

Boundless Bio operates in the biotechnology sector, which focuses on developing new medical treatments. This industry involves high research costs and long development timelines, but successful drugs can create significant value for patients and investors.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

84Matrix

Market Momentum

41.3— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.7x— Normal Volume

Today's Change

-0.89%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing BOLD across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 06:00 PM UTC

As-of 03-14-2026 17:45 UTC

Develops cancer drugs that target extra DNA in tumors and makes money by selling these treatments to hospitals and clinics.

Price sits below key moving averages, suggesting a downtrend caution as sellers have dominated recent trading showing consolidation pattern.

Technical squeeze detected near current levels, indicating breakout potential if price moves decisively from this tight range, suggesting tight range.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...